Joosten, S. C.
Odeh, S. N. O.
Koch, A.
Buekers, N.
Aarts, M. J. B.
Baldewijns, M. M. L. L.
Van Neste, L.
van Kuijk, S.
Schouten, L. J.
van den Brandt, P. A.
Tjan-Heijnen, V. C.
van Engeland, M.
Smits, K. M. http://orcid.org/0000-0003-2097-0533
Funding for this research was provided by:
Health Holland (LSHM17059 (PRECEDE))
Article History
Received: 1 September 2020
Accepted: 19 April 2021
First Online: 4 May 2021
Declarations
:
: This study was approved by the Medical Ethical Committee of the Maastricht University Medical Center.
: Not applicable.
: Manon van Engeland is co-founder and shareholder of Epify BV.